Thanks to GSK, constant research and production, BelaMaf was born: drug-conjugated antibodies thus open new frontiers in the treatment of multiple myeloma and indicated for patients whose cancer has proved resistant to the four standard therapeutic lines and who would have been otherwise directed to less effective pharmacological solutions or to palliation
#Multiple #Myeloma #Treatment #Cavo #Monoclonal #antibody #represents #therapeutic
School, the pediatrician: “Valditara proposal promotes knowledge and integration”
"The proposal of the Minister of Education and Merit to limit the presence of foreign students in classesit is positive...